Science Resources RSS Feeds
|
 |
 |
 |
Ovarian Cancer Current Events | Ovarian Cancer News | 3
|
| Page
3 of
95 |
1885 Results |
|
|
|
Sort By:
Page Views | Date |
Nanoparticle-delivered 'suicide' genes slowed ovarian tumor growth
Nanoparticle delivery of diphtheria toxin-encoding DNA selectively expressed in ovarian cancer cells reduced the burden of ovarian tumors in mice, and researchers expect this therapy could be tested in humans within 18 to 24 months, according to a report in Cancer Research, a journal of the American Association for Cancer Research. view more (2009-07-30)
FDA approved leukemia drugs shows promise in ovarian cancer cells
The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a study by researchers with UCLA's Jonsson Comprehensive Cancer Center found. view more (2009-11-10)
Glypican-3 gene function in regulating body size helps inform novel cancer treatments
In a leading study that has implications for the development of novel therapies for a number of breast, lung and ovarian cancers that have lost the expression of a gene called glypican-3 (GPC3), Sunnybrook researchers have discovered how the loss of the GPC3 gene induces overgrowth through certain growth factors such as Sonic Hedgehog which... view more... (2008-05-13)
Yale test detects early stage ovarian cancer with 99 percent accuracy
Researchers at Yale School of Medicine have developed a blood test with enough sensitivity and specificity to detect early stage ovarian cancer with 99 percent accuracy. view more (2008-02-13)
RNA splicing factor implicated in ovarian tumor cell growth
An RNA-binding protein that is overproduced in ovarian cancer may present a new target for diagnosis or treatment of ovarian and other cancers, according to researchers at the University of Illinois at Chicago. view more (2007-04-10)
Study reveals why certain ovarian cancers develop resistance to platinum-based chemotherapy
A team of researchers led by Fred Hutchinson Cancer Research Center has identified a new mechanism that explains why some recurrent ovarian tumors become resistant to treatment with commonly used platinum-based chemotherapy drugs such as cisplatin and carboplatin. They describe their research online Feb. 10 in the journal Nature. view more (2008-02-11)
Nursing study concludes few Ontario women with invasive ovarian cancer referred for genetic testing of breast cancer genes
An Ontario study of 491 women with invasive ovarian cancer found only a small proportion, 19%, were referred for genetic testing of BRCA1 and BRCA2, the breast cancer genes, which means family members are not informed of their cancer risk. view more (2008-12-05)
UK researchers raise hopes of preserving fertility for women with cancer
UK fertility experts have sounded a note of cautious optimism about the safety of preserving ovarian tissue and transplanting it back into women after cancer treatment. The optimism follows research reported today (Thursday 27 September) in Human Reproduction*, Europe's leading journal of reproductive medicine. It is the first reported non-test... view more... (2001-09-23)
Promising new treatment option for women with recurrent ovarian cancer
Combining the new drug trabectedin with pegylated liposomal doxorubicin provides clinical benefit to women with relapsed ovarian cancer, according to new results presented at the 33rd Congress of the European Society for Medical Oncology (ESMO) in Stockholm. view more (2008-09-16)
New treatment in sight for ovarian cancer
In the future, women with metastatic ovarian cancer could be treated with a radioactive substance that can seek and destroy tumour cells. view more (2009-08-31)
Metals could forge new cancer drug
Drugs made using unusual metals could form an effective treatment against colon and ovarian cancer, including cancerous cells that have developed immunity to other drugs, according to research at the University of Warwick and the University of Leeds. view more (2009-10-19)
Mass. General study finds potential ovarian cancer stem cells
Massachusetts General Hospital (MGH) researchers have identified potential ovarian cancer stem cells, which may be behind the difficulty of treating these tumors with standard chemotherapy. view more (2006-07-24)
Symptom screening plus a simple blood test improves early detection of ovarian cancer
Women's reports of persistent, recent-onset symptoms linked to ovarian cancer - abdominal or pelvic pain, difficulty eating or feeling full quickly and abdominal bloating - when combined with the CA125 blood test may improve the early detection of ovarian cancer by 20 percent. view more (2008-06-23)
2 reproductive factors are important predictors of death from ovarian cancer
Researchers from the Centers for Disease Control and Prevention (CDC) found that survival among women with ovarian cancer is influenced by age of menarche and total number of lifetime ovulatory cycles. view more (2009-07-09)
New study reports increased response to therapy with no added toxicity in treatment of recurrent ovarian cancer
In a study released today at the Society of Gynecologic Oncologists 37th Annual Meeting on Women's Cancer, researchers found the addition of thalidomide to topotecan for the treatment of recurrent ovarian cancer significantly increases the response to therapy and the duration of progression free survival without additional toxicity. view more (2006-03-27)
Combining therapies can improve survival for early-stage breast cancer patients
Patients with early-stage breast cancer who are treated with both chemotherapy and tamoxifen have a higher survival rate than patients who receive only tamoxifen. view more (2007-04-04)
Women with advanced ovarian cancer survive longer when treated with paclitaxel (Taxol) and cisplatin than with cyclophosphamide-cisplatin therapy
Embargoed for release: Tuesday 22 October, 09.30 (Europe), 08.30 (GMT) Women with advanced ovarian cancer survive longer when treated with Taxol (paclitaxel) and cisplatin than with cyclophosphamide-cisplatin... view more... (2002-10-19)
Scientists report the first live births in large mammals after using frozen ovarian tissue
Lausanne, Switzerland: French scientists have succeeded in using previously frozen ovarian tissue to produce live offspring in large mammals for the first time. The team, led by Professor Bruno Salle and Dr Jacqueline Lornage of the Departement de Médecine de la Reproduction at the Hôpital Edouard Herriot in Lyon, reported that from... view more... (2001-07-01)
'Clumping' protein linked to return of ovarian cancer
Johns Hopkins scientists have discovered that women treated for ovarian cancer are at increased risk of a rapid and potentially fatal recurrence if their tumor cells have high levels of a binding protein that triggers abnormal growth and slows down cell death, both hallmarks of malignancy. view more (2006-12-18)
Ultrasound could help couples undergoing IVF
Ultrasound-based tests allowing women undergoing in-vitro fertilization (IVF) to count their chickens before they've hatched may provide alternatives to the hormone-based tests used today. Less costly and invasive than the current ovarian reserve tests, clinicians may in future consider using ultrasound scans of a woman's ovaries to predict her... view more... (2007-03-15)
|
|
| Page
3 of
95 |
1885 Results |
|
|
|
Sort By:
Page Views | Date |
|
|
